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design of nanomedical therapies, due 
to the important role parameters such 
as size, shape, surface chemistry, and 
ligand density have on performance in 
vivo.[1] Significant advances have been 
made using asymmetric particles as the 
basis for therapeutic nanosystems due to 
their ability to successfully navigate key 
biological barriers and enhance the effi-
cacy of specific interactions with target 
tissues.[2] For instance, high aspect ratio 
nanostructures have been shown to result 
in enhanced specific accumulation and 
reduced nonspecific adhesion to cells, 
while displaying distinct uptake mecha-
nisms.[3] The potential for asymmetric 
nano particles to improved therapeutic 
outcomes in, for example, anticancer 
drug delivery fuels interest in the devel-
opment of new processes for their manu-
facture.[4] Different processes have been 
developed for the manufacture asym-
metric microparticles, such as PRINT.[5] 
Another  versatile approach involves block 
copolymers that undergo directed self-
assembly (based upon physicochemical 
parameters associated with chain packing 
and intermolecular interactions); this 
facilitates bottom-up programming of 
asymmetric nano systems with versatile functionality.[6] Spe-
cific examples include polymerization induced self-assembly,[7] 
crystallization-driven self-assembly,[8] or osmotically induced 
shape transformation processes,[9] which result in asymmetric 
Engineering biodegradable nanostructures with precise morphological char-
acteristics is a key objective in nanomedicine. In particular, asymmetric (i.e., 
nonspherical) nanoparticles are desirable due to the advantageous effects 
of shape in a biomedical context. Using molecular engineering, it is possible 
to program unique morphological features into the self-assembly of block 
copolymers (BCPs). However, the criteria of biocompatibility and scalability 
limit progress due to the prevalence of nondegradable components and the 
use of toxic solvents during fabrication. To address this shortfall, a robust 
strategy for the fabrication of morphologically asymmetric nanoworms, com-
prising biodegradable BCPs, has been developed. Modular BCPs comprising 
poly (ethylene glycol)-block-poly(caprolactone-gradient-trimethylene car-
bonate) (PEG−PCLgTMC), with a terminal chain of quaternary ammonium-
TMC (PTMC-Q), undergo self-assembly via direct hydration into well-defined 
nanostructures. By controlling the solution ionic strength during hydration, 
particle morphology switches from spherical micelles to nanoworms (of 
varying aspect ratio). This ionically-induced switch is driven by modulation of 
chain packing with salts screening interchain repulsions, leading to micelle 
elongation. Nanoworms can be loaded with cytotoxic cargo (e.g., doxoru-
bicin) at high efficiency, preferentially interact with cancer cells, and increase 
tumor penetration. This work showcases the ability to program assembly 
of BCPs and the potential of asymmetric nanosystems in anticancer drug 
delivery.
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1. Introduction
Precisely controlling the morphology of self-assembled 
poly mer architectures is becoming a key paradigm for the 
© 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. 
KGaA, Weinheim. This is an open access article under the terms of the 
 Creative Commons Attribution-NonCommercial License, which permits 
use, distribution and reproduction in any medium, provided the original 
work is properly cited and is not used for commercial purposes.
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particles.[10] At present, there is however a dearth of polymeric 
technologies that have reached the market due to problems 
associated with producibility, toxicity, and/or reproducibility—
arising from the tendency for copolymer engineering to focus 
on the use of nonbiodegradable components and fabrication 
processes that introduce toxic solvents and result in nonuni-
form products.
In order to overcome these barriers, we have recently devel-
oped technology for the formation of biodegradable nanovec-
tors that can be fabricated using the direct hydration (DH) 
methodology.[11] The DH methodology circumvents the use 
of toxic organic solvents and is a major step toward achieving 
controlled self-assembly under more biocompatible conditions. 
Block copolymers (BCPs) comprising poly(ethylene glycol)-
poly(trimethylene carbonate) (PEG-PTMC) were utilized as 
the structural basis for drug-loaded nanovectors (NVs) that were 
fabricated using DH, whereby dissolution in oligo(ethylene 
glycol) (OEG) preceded addition of buffer and formation of pris-
tine particles that did not require any further purification prior 
to use in vitro or in vivo. Due to the highly uniform nature of 
PEG-PTMC copolymers that were prepared it was possible to 
precisely control the size of the resulting NVs; however, addi-
tional strategies are required to incorporate advanced character-
istics, such as shape, into this system.[12] Precision engineering 
of BCPs into well-defined (nano)morphologies is relatively 
unexplored—especially when using strictly biodegradable com-
ponents and using the DH approach for particle fabrication.
In terms of BCP programming, self-assembly of amphiph-
ilic copolymers is driven by hydrophobic self-association and 
modulated by the steric forces associated with the hydrated sur-
face blocks. Systematic introduction of chemical triggers (such 
as pH-responsive, thermally responsive, or ionic subunits) can 
be used to direct BCP assembly, engineering “smart” nano-
structures that are sensitive to their environment.[13] In par-
ticular, directing the self-assembly of BCPs by modulating their 
amphiphilic nature, tailoring interactions with ions in solution, 
is an effective strategy to control particle morphology.[3b,14] Tai-
loring the concentration and nature of aqueous ions is a simple 
and effective strategy to achieve controlled self-assembly and 
dictate the final morphology of BCP assemblies.[3c] In recent 
work, we have demonstrated that osmotically induced shape 
transformation can be applied to spherical polymersomes in 
order to direct formation of either nanotubes or bowl-shaped 
stomatocytes, driven by the influence of salts and solvent com-
position on BCP packing.[9a,15]
Inspired by this, we here report a strategy for the controlled 
formation of biodegradable nanoworms using an ionically 
induced trigger directing the packing of a tertiary chain com-
prising cationic derivatives of PTMC (PTMC-Q) (Figure 1). 
Molecular programming of BCPs provides a novel route toward 
the formation of cationic, asymmetric nanoworms, an exciting 
platform for applications in nanomedicine where the  elongated 
nanostructures and positive charge can enhance interactions 
with cellular surfaces and drive integration of therapeutic 
cargo.[16] Furthermore, due to the increasingly negative charge 
of cancer cell membranes, nanoparticles bearing controlled 
degrees of positive charge are capable of electrostatically driven 
specificity, a morphology driven (as opposed to ligand affinity) 
targeting mechanism.[17]
2. Results and Discussion
2.1. Molecular Programming of BCPs
Molecular programming of BCPs was accomplished 
using a modular polymerization approach; producing 
amphiphilic terpolymers with well-defined chemical 
characteristics (cf. Supporting Information). Poly(ethylene glycol)-
block-poly(caprolactone-gradient-trimethylene carbonate) (PEG- 
PCLgTMC) copolymers were utilized as the basis for this 
system due to their established capacity in generating well-
defined polymer assemblies (using the DH process) and their 
biodegradability/biocompatibility.[11,18] Although PCL is a crys-
talline polymer, PTMC counteracts this property by providing 
the necessary fluidity to enable effective chain packing whilst 
maintaining the rigidity necessary to generate higher order 
polymeric nanostructures like polymersomes.[11,19] Conversely, 
copolymers comprising PEG–PTMC alone will only form 
spherical micelles due to the flexibility of the PTMC block.[12a] 
As we have demonstrated, copolymers of PCL and PTMC can 
(under certain conditions) form worm-like structures; however, 
isolating the worm phase is challenging and requires an addi-
tional strategy to balance bilayer rigidity with the high surface 
curvature required for micelle formation.[11] To accomplish 
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Figure 1. Programming the formation of biodegradable nanoworms 
via an ionically induced morphology switch toward asymmetric thera-
peutic carriers. a) Terpolymer chemical structure and ionically induced 
morphology switch between spherical micelles and nanoworms due to 
modulation of interchain interactions (due to the presence of quaternary 
ammonium block) in the absence/presence of NaCl. b) The proposed 
membrane interactions between cationic nanoworms and (negatively 
charged) cancer cell membranes leading to enhanced membrane per-
meability and preferential delivery of therapeutic payloads. (Scale bars 
= 200 nm)
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this, we utilized copolymers based upon PEG22-PCL30gTMC30 
(≈7.5 kDa, termed as TerP22) for the engineering of asym-
metric nanoparticles. PCL30gTMC30 provide sufficient flex-
ibility to maintain the hydrophobic bilayer over extended length 
scales. Using TerP22 as a macroinitiator a bromide functional 
TMC derivative was polymerized onto the PTMC chain end.[20] 
Via a nucleophilic substitution reaction, the bromides were 
replaced by quaternary ammonium groups in order to provide 
the enhanced surface curvature required to generate (high sur-
face curvature) micellar architectures. A series of well-defined 
(Ð ≈ 1.1) terpolymers (TerP22-Q) was prepared in which the 
length of the ternary block was systematically varied yielding 
TerP22-Qn BCPs (where n = 6, 11, and 20 repeats), to investigate 
the effect of hydrophilic portion and charge density on the self-
assembly process (Scheme S1, Supporting Information).[16a] 
Because electrostatic repulsions between the highly charged 
PTMC-Q blocks will induce the formation of high surface 
curvature nanoparticles (i.e., micelles), we anticipate that the 
concentration of salt present during formation (screening elec-
trostatic repulsions) will be a key factor in controlling assembly 
of these TerP22-Q copolymers.
2.2. Nanoworms Formation via Direct Hydration
TerP22-Q BCPs were all compatible with the DH process, 
whereby a 10 wt% solution was prepared in oligo (ethylene 
glycol) (OEG) prior to addition of water (or salt solution) and 
stirring at room temperature for 5 min. TerP22-Q BCPs were 
hydrated using solutions of increasing [NaCl] from 0–400 × 
10−3 m in order to determine the effect of ionic strength on 
self-assembly. From dynamic light scattering (DLS) data it was 
evident that the structural evolution using all three copolymers 
was significantly different. In general terms, under conditions 
where the molecular volume of a hydrophilic copolymer block 
increases (e.g., due to increased molecular weight or hydration) 
dynamic assembly tends to favor the (high surface curvature) 
spherical micelle phase, where the packing parameter (P) ≤ 1/3. 
Under conditions where the hydrophilic volume decreases (or 
hydrophobic volume increases), lower surface curvature phases 
like elongated worms (or vesicles) are favored.[21] First, terpoly-
mers bearing the longest PTMC-Q terminal block (TerP22-Q20) 
appeared to form uniform micelles under all conditions 
with nearly the same hydrodynamic radius of ≈25−30 nm 
(Figure S17a–c). TerP22-Q20 did not undergo transforma-
tion into asymmetric particles due to the strong repulsions 
between cationic chains and the large hydrophilic volume, 
maximizing surface curvature (i.e., spherical micelles, SMs). 
Cryo-TEM microscopy confirmed the presence of SMs in sam-
ples of TerP22-Q20 (Figure S17d, Supporting Information), and 
 quantitative insight was obtained using asymmetric flow field-
flow fractionation (AF4) coupled with multiangle light scat-
tering (MALS) and DLS. Measurements of the shape factor (ρ) 
provided insight into nanoparticle shape by comparison of the 
radius of gyration (Rg) and Rh (ρ = Rg/Rh). Indeed,  TerP22-Q20 
SMs (hydrated into water or 200 × 10−3 m NaCl) eluted after 
10–12 min with ρ values ranging from 0.7 to 0.75, indicative 
of micelles that possess a dense core and hydrated corona 
(Figure S17e,f).
In order to reduce the strength of electrostatic repulsions 
between PTMC-Q blocks, we decreased the cationic segment 
thus reducing the volume of the quaternary ammonium block. 
In contrast to the behavior of TerP22-Q20, the self-assembly of 
TerP22-Q11 clearly showed a response to ionic strength during 
the hydration step. When hydrated in Milli-Q water, TerP22-Q11 
formed uniform spherical micelles (SMs) with hydrodynamic 
radius (Rh) of ≈22 nm (Figure 2a). Cryo-TEM microscopy, 
AF4-MALS, and DLS confirmed the presence of SMs in 
samples of TerP22-Q11 hydrated in Milli-Q water (Figure 2c). 
Indeed, TerP22-Q11 SMs eluted after 10–12 min with ρ 
values ranging from 0.7 to 0.75 (Figure 2e). However, when 
TerP22-Q11 was hydrated into salt solution with [NaCl] ≥ 100 × 
10−3 m, DLS measurements clearly identified a change in nan-
oparticle morphology with the presence of a significant popu-
lation at >100 nm (Figure 2a,b; Figure S18, Supporting Infor-
mation). Cryo-TEM clearly identified this new morphology 
as nanoworms (NWs) in samples of TerP22-Q11 hydrated into 
100–400 × 10−3 m NaCl (Figure 2d; Figure S19, Supporting 
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Figure 2. Well-defined spherical micelles (SMs) and elongated nano-
worms (NWs) comprising TerP22-Q11 terpolymers. a) DLS curve of 
TerP22-Q11 terpolymers hydrated in Milli-Q or 200 × 10−3 m NaCl. 
b) Hydrodynamic size determined by DLS measurement of TerP22-Q11 ter-
polymers hydrated in different concentrations of NaCl. Cryo-TEM images 
of c) SMs and d) NWs (scale bars = 200 nm). AF4 fractogram (scattering 
profile in black) of e) SMs hydrated in Milli-Q and f) NWs hydrated in 
200 × 10−3 m NaCl, comparing the radius of gyration (Rg, blue) to the 
hydrodynamic radius (Rh, red).
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Information). Using AF4, NWs eluted later than SMs (after 
20–22 min) and possessed characteristic shape factor (ρ) 
values of ≈1.8–2.3, indicative of highly elongated nanostruc-
tures (Figure 2f; Figure S20 and Table S3, Supporting Infor-
mation). It was apparent from AF4 data that the Rg of NWs 
tended to increase with [NaCl], which was supported by cryo-
TEM images, indicating that increasing ionic strength yielded 
more elongated worms (Figures S19 and S20, Supporting 
Information).
To further increase our understanding of this system, 
gaining further insight into the self-assembly behavior, TerP22-Q 
copolymers with shorter Q block were prepared in order 
to explore its effect on nanoparticle morphology. Further 
decreasing the length of the cationic block (TerP22-Q6) seemed 
to negate the ionically induced morphology switch, as NWs 
were observed under all conditions. DLS measurements identi-
fied that larger (>100 nm) particles formed after hydration of 
TerP22-Q6 into the water, which persisted at all salt concentra-
tions (Figure S22, Supporting Information). Cryo-TEM clearly 
identified NWs in the absence and presence of different NaCl 
concentration solutions (Figure S23, Supporting Information), 
characterized by ρ values higher than 1.7, which are indicative 
of highly elongated nanostructures (Figure S24 and Table S4, 
Supporting Information).
The unique capacity of TerP22-Qn (where n = 6 or 11) to 
undergo programmed assembly into NWs was evident when 
contrasted to control polymers like TerP22-Br6 (the synthetic 
precursor to TerP22-Q6) and TerP22-G5 (where the quater-
nary ammonium was replaced with a cationic guanidinium 
moiety—all chemical structures of copolymers synthesized 
are listed in Figure 3 and the Supporting Information). Nei-
ther TerP22-Br6 nor TerP22-G5 showed any capacity to undergo 
assembly into well-defined NWs and, instead, formed well-
defined SMs (Figure S26, Supporting Information). Although 
this property was expected from uncharged TerP22-Br6, it was 
surprising that the cationic guanidinium analogue did not 
form NWs in the same fashion as the quaternary ammonium 
derivate TerP22-Q6. This was likely caused by the distinct nature 
of the head group, TerP22-G5; resulting in higher surface curva-
ture, which could not be overcome even upon addition of up to 
400 × 10−3 m NaCl. Presumably, this behavior was caused by the 
frustrated packing of the side chain and strong hydration forces 
of the guanidinium moiety, driving the formation of high sur-
face curvature (spherical) micelles.[22] The significant impact 
molecular design has upon the resulting morphology was fur-
thermore illustrated when the 1 kDa PEG block was replaced 
by a 2 kDa chain. Indeed, the 2 kDa PEG-based TerP44-Q20 
underwent assembly into elongated NWs at a high concentra-
tion of NaCl (Figures S27 and S28, Supporting Information), 
however, they were significantly reduced in length and the pro-
portion of SMs when hydrated in ≤400 × 10−3 m NaCl solution 
was much greater compared to the 1 kDa analogue (Figure S27, 
Supporting Information). The above observations provide evi-
dence to support the role of PTMC-Q in directing the ionically 
induced morphology switch of TerP22 copolymers (Figure 3). 
Taken together this highlights the unique capacity of TerP22-Q 
BCPs to undergo self-assembly into NWs, programmed into the 
molecular structure and giving rise to unique supramolecular 
behavior.
2.3. Nanoworms Enhance Cell Membrane Interactions
As already mentioned, high aspect-ratio nanostructures are 
exciting targets for nanomedical investigation due to their 
improved biological performance and ability to enhance inter-
actions with living cells.[23] In particular, the ability to direct 
nanoparticles toward cancer cells, which typically possess more 
negative surface charge, using electrostatic targeting is an appli-
cation deserving further investigation as a general strategy to 
increase the specificity of anticancer therapies.[17a,24] With this 
in mind, we undertook preliminary testing to explore the advan-
tageous properties of NWs comprising TerP22-Q11, comparing 
them to SMs and an uncharged nanoparticle control system 
(UPs), comprising PEG22-PCL30gTMC30.[11] First, the stability 
of SMs and NWs comprising TerP22-Q11 when transferred into 
PBS or cell culture medium, of critical importance for potential 
application in biomedical research, was confirmed using DLS 
(Figures S30–S32, Supporting Information). Particle stability 
was confirmed when no changes in the correlation data were 
observed during incubation under physiological conditions. 
Indeed, sodium dodecyl sulfate (SDS) micelles only undergo 
spontaneous morphological transitions when [NaCl] reached 
1m, which is well above physiological conditions.[25] The critical 
aggregation concentration (CAC) was determined using a 1-ani-
lino-8-naphthalenesulfonate (ANS) assay. CAC values of SMs 
were measured at ≈0.030 mg mL−1 (2.7 × 10−6 m), with NWs 
displaying a slightly lower CAC at ≈0.022 mg mL−1 (2.0 × 10−6 m) 
(Figure S33, Supporting Information). Zeta-potential meas-
urements of TerP22-Q11 SMs and NWs highlighted the same 
charge characteristics in both systems (as expected) with values 
of 25 ± 3 mv and 27 ± 4 mV, respectively, which can drive elec-
trostatic interactions with the anionic cancer cell membrane 
(Figure S34, Supporting Information).
Conducting in vitro studies we found that, indeed, adhesion 
to cancer cells (HepG2) was enhanced for cationic particles. 
Small 2019, 1901849
Figure 3. a) Chemical structure of different terpolymers based on PEG-
PCLgPTMC; b) Particle characterization of terpolymers self-assembled via 
direct hydration into i) water, ii) 200 × 10−3 m, or iii) 600 × 10−3 m NaCl.
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Elongated NWs showed a twofold increase in binding to cancer 
cell membranes as compared to SMs, which is understandable 
given the polyvalent nature of interactions between high aspect 
ratio structures and the external cell membrane (Figures 4a,b 
and Figure S35 of the Supporting Information). To explore the 
potential of cationic NWs to interact specifically with cancer 
cells we compared the effect of the presence of NWs on the 
viability of HeLa, HepG2, and MCF-7 cells with multidrug 
resistant MCF-7/ADR and healthy fibroblast (NIH 3T3) cells 
(Figure 4c–g). Uncharged control particles (UPs) did not show 
any significant toxicity toward any cell lines at concentrations 
of up to 0.5 mg mL−1 (cell viability ≥ 90%). However, both SMs 
and NWs displayed toxicity toward cancer cells, as evidenced by 
the low IC50 in HeLa cells (SMs IC50: 28.41 µg mL−1. NWs IC50: 
13.8 µg mL−1; Figure 4c), HepG2 cells (SMs IC50: 207.1 µg mL−1. 
NWs IC50: 27.9 µg mL−1; Figure 4d), and MCF-7 cells (SMs 
IC50: 21.0 µg mL−1. NWs IC50: 1.1 µg mL−1; Figure 4e, Table S6 
of the Supporting Information). This toxicity was significantly 
reduced with drug-resistant cell line MCF-7/ADR (SMs IC50 > 
500 µg mL−1; NWs IC50: 419 µg mL−1; Figure 4f), or healthy cell 
line NIH 3T3 (SMs IC50 > 500 µg mL−1; NWs IC50: 354 µg mL−1; 
Figure 4g). Specific toxicity against cancer cells can be 
explained by the higher abundance of anionic lipids in the lipid 
membrane; this selectivity of the cationic polymer assemblies 
for cancer cells highlights their therapeutic potential. However, 
we should note that this specificity does not necessarily extend 
to all cancer cell types, with drug-resistant MCF-7/ADR cells 
resisting this behavior.
2.4. Penetration into 3D Tumor Multicellular Spheroids
Furthermore, to demonstrate the capacity of NWs toward anti-
cancer therapy we examined their ability to penetrate into a 3D 
tumor model. Indeed, we found that the enhanced interactions 
between NWs and the cell membrane, besides the distinctive 
elongated morphology, resulted in improved permeation into 
3D multicellular spheroids comprising cancer and healthy 
fibroblast cells (HeLa:3T3 = 1:5) (Figure 5a).[26] After 18 h incu-
bation, it was apparent that BODIPY-labeled NWs outperformed 
Chlorin e6 (Ce6)-labeled SMs in the same spheroid—a prop-
erty uniquely connected to their morphology due to the iden-
tical nature of the BCPs in both cases (Figure S36, Supporting 
Information). Furthermore, incubation of spheroids with 
either BODIPY-labeled SMs or BODIPY-labeled NWs further 
confirmed this, highlighting that high-aspect ratio NWs have 
enhanced tumor penetration propensity under physiological 
conditions (Figure S37, Supporting Information). Although this 
enhanced penetration can potentially be tuned through closer 
control over the aspect ratio of asymmetric nano particles,[27] 
our present system possesses a relatively wide range of aspect 
ratios in excess of 4 (according to cryo-TEM data, cf. Figure S19 
of the Supporting Information).
2.5. Chemotherapy toward MDR Cells
Loading particles with a model chemotherapeutic drug (doxo-
rubicin, DOX) was conducted in order to demonstrate drug 
delivery capacity that, when combined with electrostatic tar-
geting of cancer cells, could have potential as a nanomedical 
technology.[28] DOX-loaded SMs and NWs (fabricated with 
83 ± 6% efficiency and 4.1 ± 0.3 wt% loading; Figure S38, Sup-
porting Information) showed effective delivery into cells after 
only 1 h incubation time, concomitant with particle uptake by 
cells (Figure 5b; Figure S39, Supporting Information). Signifi-
cantly, SMs and NWs were able to improve the DOX  retention 
in the cell nucleus against a resistant cell line (MCF-7/
ADR), when compared with free DOX and DOX-loaded UPs 
(Figure 6a; Figures S40 and S41, Supporting Information). This 
effect was likely enhanced through strong interactions with 
(and subsequent destabilization of) the plasma membrane. 
Indeed, increased permeability of MCF-7/ADR cells (as indi-
cated by propidium iodide, PI, signal—Figure 6b; Figure S42, 
Small 2019, 1901849
Figure 4. In vitro performance of SMs and NWs comprising TerP22-Q11. a) Confocal images of HepG2 cells treated with Ce6-labeled SMs and NWs 
from TerP22-Q11 for 2 h (scale bar = 50 µm, blue: Hoechst; green: cell mask; red: NWs.). b) relative fluorescent intensity of red channels in a) analyzed 
by Image J. Cell viability of c) HeLa cells, d) HepG2 cells, e) MCF-7 cells, f) MCF-7/ADR, and g) NIH 3T3 cells after treatment with different concentra-
tions of PEG-PCLgTMC nanoparticles (UPs), SMs, and NWs.
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 Supporting Information) and enhanced ROS induc-
tion (Figure 6c; Figure S43, Supporting Information) after 
 incubation with SMs and NWs (as compared to UPs) clearly 
demonstrated the destabilizing effect of these charged nano-
particles. As a result, SMs and NWs were able to improve the 
efficacy of DOX against MCF-7/ADR cells, decreasing the IC50 
from > 25 µg mL−1 down to 3.0 and 1.9 µg mL−1, respectively 
(Figure 6d; Table S7, Supporting Information), as compared to 
UPs. Even though specific binding to MCF-7/ADR cells was not 
as pronounced as other cancer cell lines, a marked increase in 
the efficacy of DOX was observed, likely due to enhanced drug 
bioavailability within this resistant cell line. Such mechanisms 
for overcoming drug-resistance, by enhancing intracellular 
drug delivery, can provide exciting new pathways for anticancer 
therapeutics.[29]
3. Conclusion
In summary, we have applied the direct hydration approach for 
the preparation of well-controlled biodegradable nanoworms, 
with high-aspect ratio, generated through an ionically induced 
morphology switch of cationic terpolymer molecules. This pro-
vides a new direction for the engineering of nanoparticles with 
tailored morphologies and properties that can be applied as 
therapeutic carriers for synergistic drug delivery. Although the 
biochemical mechanism will certainly need further exploration, 
the observed cancer specificity of positively charged nanow-
orms (with improved tumor penetration and directed drug 
uptake) makes this an exciting system, with great potential for 
biomedical research where shape and size control is of critical 
importance.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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Figure 6. In vitro performance of drug-loaded SMs and NWs comprising 
TerP22-Q11. a) Average DOX intensity in the nucleus obtained by confocal 
images and analyzed by Image J after cells were incubated with free DOX 
(black), DOX@UPs (red), DOX@SMs (green) or DOX@NWs (blue). 
b) Fluorescence intensity of propidium iodide (PI) in MCF-7/ADR cells 
and c) intracellular ROS (assessed by CM-DCF fluorescence) after treat-
ment with PBS, 500 µg mL−1 of UPs (black), SMs (red), or NWs (blue) 
(for 24 h and using 0.5 × 10−3 m H2O2 challenge for 5 min as a control 
in the ROS study). d) Cell viability of MCF-7/ADR cells after treatment 
with either free DOX (black), DOX@UPs (red), DOX@SMs (green), or 
DOX@NWs (blue). Significance was assessed using one-way ANOVA, 
followed by Tukey’s multiple comparisons test (*P < 0.05, **P < 0.01, 
***P < 0.001).
Figure 5. In vitro performance of SMs and NWs comprising TerP22-Q11. a) Confocal images displaying penetration of SMs and NWs coincubated with 
3D HeLa: 3T3 multicellular spheroids (MCSs, Scanning depth: 30 µm. Blue: Hoechst; Green: BODIPY dye-labeled NWs; Red: SMs, scale bar = 100 µm, 
inset: zoom in of the imaging). b) Confocal images of HepG2 cells treated with DOX-loaded NWs for 1 h (scale bar = 50 µm. Blue: Hoechst; Green: 
BODIPY dye-labeled NWs; Red: DOX).
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